|
Honors & Other Things |
|
February 2, 2016, Volume 62, No. 21 |
Murray Grossman: Legal Clinic for the Disabled’s Special Recognition Award
Gary Lichtenstein and Gary Wu: IBD Scientific Achievement Awards
Anil K. Rustgi: ACS Research Professor Award
Penn Prevention Research Center: $1.4 Million for New Research
Pennsylvania Hospital: Magnet® Recognition
Thomas Tartaron: AIA James R. Wiseman Book Award
Julia Verkholantsev: Early Slavic Studies Association Book Prize
Murray Grossman: Legal Clinic for the Disabled’s Special Recognition Award
Murray Grossman, a professor of neurology in the Perelman School of Medicine at the University of Pennsylvania and director of Penn’s Frontotemporal Degeneration (FTD) Center, received the Legal Clinic for the Disabled’s Special Recognition Award, the organization’s highest honor, for his lifetime commitment to the disability community.
Dr. Grossman is recognized for his impact on the disability community through his research, writing and the care of patients with FTD and related disorders.
He is also president of the Katie Samson Foundation, a local foundation providing funding for promising research and rehabilitation treatments and programs that afford patients with spinal cord injuries independence and quality of life.
|
Gary Lichtenstein and Gary Wu: IBD Scientific Achievement Awards
Penn Medicine’s Gary Lichtenstein, professor of medicine, and Gary Wu, the Ferdinand G. Weisbrod Professor in Gastroenterology, received 2015 Inflammatory Bowel Disease (IBD) Scientific Achievement Awards from the Crohn’s & Colitis Foundation of America (CCFA). The awards were given at the CCFA’s annual Advances in Inflammatory Bowel Diseases Conference in Orlando, Florida in December.
Dr. Lichtenstein was awarded the Scientific Achievement in IBD Clinical Research Award. He has led Penn’s Inflammatory Bowel Disease Center for 22 years. He currently researches investigational therapies for ulcerative colitis (UC) and Crohn’s disease treatments. He has served as the principal investigator in trials evaluating novel agents in the treatment of UC and Crohn’s disease.
Dr. Wu won the Scientific Achievement in Basic IBD Research Award. He serves as associate chief for research in gastroenterology, co-director of the Penn-CHOP Microbiome Program and associate director of Penn’s Center for Molecular Studies in Digestive and Liver Disease. He is also an elected member of the American Society for Clinical Investigation and the Association of American Physicians.
|
Anil K. Rustgi: ACS Research Professor Award
Anil K. Rustgi, chief of gastroenterology in the Perelman School of Medicine at the University of Pennsylvania, is once again the recipient of a Research Professor Award from the American Cancer Society (ACS), the organization’s most prestigious national award. It comes with a grant of five years to enable Dr. Rustgi to continue to provide leadership in his research on the genetics and biology of gastrointestinal cancers, including those arising from the colon and pancreas. His group has provided innovative scientific contributions in the development of 3D culture systems, mouse models and bridging the preclinical arena and clinical domains.
The Rustgi lab has long focused on how preneoplastic cells become neoplastic and the tumor microenvironment. With the ACS grant and other efforts, the lab is increasingly interested in GI cancer metastasis biology and avenues to target metastatic lesions in patients.
Dr. Rustgi is one of only 25 active ACS Research Professors in the country. He was first awarded an ACS professorship award in 2010. This is a one-time, five-year renewal.
|
Penn Prevention Research Center: $1.4 Million for New Research
The University of Pennsylvania Prevention Research Center has received $1.4 million from the Centers for Disease Control and Prevention (CDC) for three new special interest projects.
The first project is a two-year initiative that aims to build community health leadership in West Philadelphia to prevent chronic disease. Frances Barg, a medical anthropologist and associate professor in the department of family medicine & community health, is the principal investigator. Co-investigators are Heather Klusaritz, Peter Cronholm, Chyke Doubeni and Karen Glanz.
The second is a three-year project led by Christine Hill-Kayser, assistant professor of radiation oncology, and Lisa Schwartz, assistant professor of clinical psychology in pediatrics at the Children’s Hospital of Philadelphia. They will test the impact of a technology-based intervention to provide customized care plans and a mobile health application to help adolescents and young adults who are childhood cancer survivors take a greater role in managing their health. Co-investigators are Lamia Barakat, Lauren Daniel, Linda Fleisher, Jill Ginsberg, Wendy Hobbie, Linda Jacobs, Yimei Li and Dava Szalda.
The third is a two-year effort that will compare the economic impact and health-related quality of life outcomes among children with cancer who were treated in phase III clinical trials to those who received non-trial standard treatment. The principal investigator is Marilyn Schapira, associate professor of medicine at the Corporal Michael J. Crescenz Veteran’s Administration Medical Center and co-leader of the Cancer Control Research Program at the Abramson Cancer Center. Co-investigators are Lamia Barakat, Charles Bailey and Jeffrey Silber.
|
Pennsylvania Hospital: Magnet® Recognition
Pennsylvania Hospital (PAH) achieved Magnet® status, the highest institutional honor awarded for nursing excellence, from the American Nurses Credentialing Center (ANCC). PAH’s achievement was granted unanimously by the ANCC’s Commission on Magnet®.
Magnet® status is one of the highest achievements a hospital can obtain in professional nursing. Less than 7% of healthcare organizations in the United States have achieved the designation. All five Penn Medicine acute care facilities—PAH, the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital and Lancaster General Health—are now among the 27 Magnet® hospitals in Pennsylvania.
|
Thomas Tartaron: AIA James R. Wiseman Book Award
Thomas Tartaron, associate professor of classical studies, won the Archaeological Institute of America’s (AIA) James R. Wiseman Book Award for best archaeological book of the year for Maritime Networks in the Mycenaean World, which takes a new look at maritime life among the Mycenaean Greeks from 1600-1100 B.C. While the Greeks’ long-distance trade with Egypt and Cyprus has been substantially studied, local maritime networks have been largely ignored and the locations of Mycenaean harbors are virtually unknown. In his book, Dr. Tartaron provides concepts and methods for recovering lost harbors and short-range maritime networks using information from ship construction, coastal paleoenvironments, oral histories, Homer and other ancient texts, archaeological fieldwork and network theory.
|
Julia Verkholantsev: Early Slavic Studies Association Book Prize
Julia Verkholantsev, associate professor of Slavic languages and literatures, received the Early Slavic Studies Association Book Prize for The Slavic Letters of St. Jerome: The History of the Legend and Its Legacy, or, How the Translator of the Vulgate Became an Apostle of the Slavs. The book explores the history of the medieval belief that fourth-century church father and biblical translator St. Jerome was a Slav and the inventor of the Slavic (Glagolitic) alphabet and Roman Slavonic rite, and investigates this belief’s spread from Dalmatia to Bohemia and Poland. Now largely forgotten, this legend was used by political and religious leaders from Rome to Bohemia and beyond for nearly 500 years until it was debunked in the 18th century. Dr. Verkholantsev examines the belief within the wider context of European historical and theological thought and shows that its effects reached far beyond the Slavic world.
|
|
Almanac -
February 2, 2016, Volume 62, No. 21
|
|
|